The fibrate-activated PPARα/p16INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusion

被引：1

作者：

Gizard, F ^{[1
]}

Staels, B ^{[1
]}

机构：

[1] Univ Lille 2, INSERM, U 545, Dept Atherosclerose,Inst Pasteur Lille, F-59019 Lille, France

来源：

M S-MEDECINE SCIENCES | 2006年 / 22卷 / 04期

关键词：

D O I：

10.1051/medsci/2006224351

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：351 / 353

页数：3

共 13 条

[1]

Carmeliet P, 1997, CIRC RES, V81, P829

[2] Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies [J].

Dzau, VJ ;

Braun-Dullaeus, RC ;

Sedding, DG .

NATURE MEDICINE, 2002, 8 (11) :1249-1256

[3]

Froeschl M, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P103, DOI 10.2174/1568006043481293

[4] PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a [J].

Gizard, F ;

Amant, C ;

Barbier, O ;

Bellosta, S ;

Robillard, R ;

Percevault, F ;

Sevestre, H ;

Krimpenfort, P ;

Corsini, A ;

Rochette, J ;

Glineur, C ;

Fruchart, JC ;

Torpier, G ;

Staels, B .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3228-3238

[5] Arterial smooth muscle cell heterogeneity - Implications for atherosclerosis and restenosis development [J].

Hao, HY ;

Gabbiani, G ;

Bochaton-Piallat, ML .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1510-1520

[6] Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice [J].

Krimpenfort, P ;

Quon, KC ;

Mooi, WJ ;

Loonstra, A ;

Berns, A .

NATURE, 2001, 413 (6851) :83-86

[7] CYCLINS, CYCLIN-DEPENDENT KINASES AND CDK INHIBITORS - IMPLICATIONS IN CELL-CYCLE CONTROL AND CANCER [J].

MACLACHLAN, TK ;

SANG, NL ;

GIORDANO, A .

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1995, 5 (02) :127-156

[8] Peroxisome proliferator-activated receptors and atherogenesis - Regulators of gene expression in vascular cells [J].

Marx, N ;

Duez, H ;

Fruchart, JC ;

Staels, B .

CIRCULATION RESEARCH, 2004, 94 (09) :1168-1178

[9] Peroxisome-proliferator-activated receptors and cancers: Complex stories [J].

Michalik, L ;

Desvergne, B ;

Wahli, W .

NATURE REVIEWS CANCER, 2004, 4 (01) :61-70

[10] Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial [J].

Robins, SJ ;

Collins, D ;

Wittes, JT ;

Papademetriou, V ;

Deedwania, PC ;

Schaefer, EJ ;

McNamara, JR ;

Kashyap, ML ;

Hershman, JM ;

Wexler, LF ;

Rubins, HB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (12) :1585-1591

← 1 2 →